Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+43.2%
5Y CAGR+33.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+43.2%/yr
vs +17.1%/yr prior
5Y CAGR
+33.6%/yr
Recent acceleration
Acceleration
+26.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.3x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $448.73M | +60.1% |
| 2024 | $280.32M | +52.1% |
| 2023 | $184.26M | +20.6% |
| 2022 | $152.85M | +24.9% |
| 2021 | $122.36M | +16.2% |
| 2020 | $105.33M | +4.9% |
| 2019 | $100.36M | +23.5% |
| 2018 | $81.29M | +30.2% |
| 2017 | $62.42M | +38.0% |
| 2016 | $45.24M | - |